BioCentury This Week

BioCentury製作的BioCentury This Week

BioCentury

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.

For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

分类: 科學與醫學

听听最后一集:

A pathway proposed by FDA to cut the time it takes biopharma companies to get to first-in-human trials is more ambitious than similar policies in Australia, China and the U.K. On the latest BioCentury This Week podcast, BioCentury’s analysts assess the proposal, as well as a concession for the biopharma industry on first-in-human studies in PDUFA reauthorization negotiations with FDA. The analysts also discuss the latest pair of billion-dollar biotech deals: Gilead's $3.2 billion takeout of a...

以前的剧集

  • 370 - Ep. 360 - FDA’s FIH plans. Plus: billion-dollar deals, funds 
    Mon, 13 Apr 2026
  • 369 - Ep. 359 - 2Q markets preview, tariffs and biotech takeouts 
    Mon, 06 Apr 2026
  • 368 - Ep. 358 - Europe's biotech challenge 
    Wed, 01 Apr 2026
  • 367 - Ep. 357 - Deal-O-rama, Gilead and Tallon's U.K. vision 
    Mon, 30 Mar 2026
  • 366 - Ep. 356 - Arrowhead’s arc. Plus: AI in biotech venture, Synnovation, MFN 
    Mon, 23 Mar 2026
显示更多剧集

更多中文 科學與醫學 podcasts

更多国际 科學與醫學 podcasts

選擇 Podcast 類型